Search research articles
Contact Us
Filters
Showing results (111-120 of 113) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 113 results.
Cancer Discovery
|
July 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Kanwal Raghav, Suyu Liu, Michael J Overman, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Eugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 113) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 113 results.
Cancer Discovery
|
July 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Kanwal Raghav, Suyu Liu, Michael J Overman, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Eugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Page
of 12